Qlucore Ab (Publ) (QCORE.ST)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in SEK| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | SEK m | 13 | 14 | 13 | 14 | 10 | 7 | 8 | - |
| Operating profit | SEK m | -28 | -37 | ||||||
| Net profit | SEK m | -6 | -12 | -16 | -16 | -21 | -37 | -33 | - |
| EPS reported | SEK | -1.22 | -1.01 | ||||||
| Operating cashflow per share | SEK | -0.42 | -0.29 | ||||||
| Capex per share | SEK | 0.00 | 0.19 | ||||||
| FCF per share | SEK | -0.42 | -0.38 | ||||||
| Free cash flow | SEK m | -13 | -14 | ||||||
| Net debt | SEK m | -2 | -5 | ||||||
| Book value equity | SEK m | 36 | 33 | ||||||
| Book value per share | SEK | 1.21 | 0.76 | ||||||
| Number of shares | m | 29.94 | 43.94 | ||||||
| DPS (TTM paid) | SEK | 0.00 | 0.00 |
Financial summary
Financials in SEK| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.20 | 0.22 | ||||||
| P/S LTM | x | 1.07 | 0.95 | ||||||
| P/FCF LTM | x | -0.58 | -0.52 | ||||||
| EV/EBITDA LTM | x | -0.19 | -0.12 | ||||||
| EV/Sales LTM | x | 1.83 | 0.15 | ||||||
| Earnings Yield LTM | % | -2.62% | -2.60% | ||||||
| FCF Yield | % | -173.52% | -191.95% | ||||||
| Quality | |||||||||
| ROE | % | -100.60% | -85.56% | ||||||
| ROIC | % | -74.28% | -1.07% | ||||||
| Operating margin | % | -4.16% | -6.02% | ||||||
| Gross margin | % | -3.04% | -3.04% | ||||||
| FCF/Sales | % | -185.71% | -239.51% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -34.00% | -25.82% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -8.94 | -11.07 | ||||||
| Net Debt/EBITDA | x | 0.08 | 0.04 | ||||||
| EBIT/Net interest | x | -144.38 | -208.89 | ||||||
| Net debt/market cap | % | +10.05% | +53.82% | ||||||
| Net debt/Equity | x | -0.04 | -0.14 | ||||||
| Gross debt/equity | x | 0.04 | 0.04 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Based in Lund, Sweden, Qlucore AB (publ) delivers advanced bioinformatics data analysis tools for global application in both scientific research and accurate medical diagnostics. Its product suite includes Qlucore Omics Explorer, an AI-powered bioinformatics software designed for research across various sectors such as life science, biotechnology, food, plant industries, and academia. Additionally, the company offers Qlucore Diagnostics, a specialized software platform for multi-omics companion and precision diagnostics, as well as Qlucore Insights, which facilitates the analysis of clinical data. Qlucore was established in 2007.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Based in Lund, Sweden, Qlucore AB (publ) delivers advanced bioinformatics data analysis tools for global application in both scientific research and accurate medical diagnostics. Its product suite includes Qlucore Omics Explorer, an AI-powered bioinformatics software designed for research across various sectors such as life science, biotechnology, food, plant industries, and academia. Additionally, the company offers Qlucore Diagnostics, a specialized software platform for multi-omics companion and precision diagnostics, as well as Qlucore Insights, which facilitates the analysis of clinical data. Qlucore was established in 2007.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free